Minapharm Pharmaceuticals (CAI:MIPH) Total Stockholders Equity : E£4,323 Mil (As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals Total Stockholders Equity?

Minapharm Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2024 was E£4,323 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Minapharm Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2024 was E£351.68. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Minapharm Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2024 was 1.30.

Minapharm Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for Minapharm Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals Total Stockholders Equity Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

Total Stockholders Equity

2,958.76

3,422.71

Minapharm Pharmaceuticals Quarterly Data
	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial			-	-	3,422.71	3,968.70	4,323.16

Minapharm Pharmaceuticals (CAI:MIPH) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Minapharm Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4323.155	-	0)	/	12.293
	=	351.68

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Minapharm Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3156.981	+	2451.371)	/	4323.155
	=	1.30

Minapharm Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Minapharm Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

https://www.minapharm.com

Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines